# Stage 5 Blind-Spot Analysis & Taxonomy Report

## Executive Summary
This report details the empirical analysis of vulnerability regions identified across Stages 1 to 4. Rather than testing models on common, in-distribution scenarios, Stage 5 systematically targets 15 defined blind-spot categories (`BS01` to `BS15`) evaluated across tabular ML, deep learning, clinical NLP, and small language model generation.

## Blind-Spot Taxonomy & Priority Ranking

| Blind Spot | Name | Affected Stages | Priority Score | Tier | Failure Rate | Underrep | Disagreement |
|:---|:---|:---|:---:|:---:|:---:|:---:|:---:|
| `BS12` | Cross-stage disagreement | All Stages | 0.8100 | **CRITICAL** | 0.70 | 0.80 | 0.90 |
| `BS14` | Resistance pattern | Stage 3, 4 | 0.7810 | **CRITICAL** | 0.68 | 0.90 | 0.65 |
| `BS09` | Conflicting clinical signals | Stage 1, 4 | 0.7650 | **CRITICAL** | 0.65 | 0.85 | 0.70 |
| `BS02` | Rare mutation co-occurrence | Stage 3, 4 | 0.7395 | **CRITICAL** | 0.58 | 0.95 | 0.55 |
| `BS15` | Dataset coverage gap | All Stages | 0.6975 | **HIGH** | 0.50 | 0.95 | 0.50 |
| `BS04` | Conflicting biomarkers | Stage 1, 2 | 0.6925 | **CRITICAL** | 0.50 | 0.80 | 0.65 |
| `BS10` | Low-confidence prediction pattern | Stage 1, 3 | 0.6800 | **HIGH** | 0.60 | 0.65 | 0.55 |
| `BS11` | High-confidence wrong prediction | Stage 1 | 0.6700 | **CRITICAL** | 0.75 | 0.60 | 0.65 |
| `BS05` | Rare adverse event | Stage 1, 3 | 0.6350 | **HIGH** | 0.40 | 0.90 | 0.45 |
| `BS08` | Temporal complexity | Stage 2, 4 | 0.6135 | **HIGH** | 0.42 | 0.80 | 0.45 |
| `BS03` | Sparse biomarker region | Stage 1 | 0.6075 | **HIGH** | 0.45 | 0.75 | 0.40 |
| `BS01` | Underrepresented mutation | Stage 1, 4 | 0.5900 | **HIGH** | 0.35 | 0.85 | 0.40 |
| `BS13` | Unusual treatment history | Stage 1, 4 | 0.5900 | **MEDIUM** | 0.40 | 0.75 | 0.45 |
| `BS07` | Negation-heavy text | Stage 3, 4 | 0.5875 | **HIGH** | 0.55 | 0.60 | 0.50 |
| `BS06` | Missing clinical information | Stage 1, 4 | 0.5690 | **HIGH** | 0.38 | 0.70 | 0.40 |

## Priority Scoring Methodology
Stress-Test Priority Score (STPS) is computed using weighted multi-objective empirical factors:
$$\text{STPS} = 0.30 \cdot S_{\text{fail}} + 0.20 \cdot S_{\text{underrep}} + 0.20 \cdot S_{\text{disag}} + 0.15 \cdot S_{\text{uncert}} + 0.10 \cdot S_{\text{rarity}} + 0.05 \cdot S_{\text{reprod}}$$

Critical-tier blind spots (`STPS >= 0.70`) demonstrate severe failure consequences or high cross-stage disagreement.
